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Abstract
Background: Electronic cigarettes (ECs) are increasingly used for reducing or stopping smoking, with some studies
showing positive outcomes. However, little is known about views on ECs during pregnancy or postpartum and
previous studies have nearly all been conducted in the US and have methodological limitations, such as not
distinguishing between smokers and ex/non-smokers. A greater understanding of this topic will help to inform
both clinicians and EC interventions. We elicited views and experiences of ECs among UK pregnant or recently
pregnant women.
Methods: We conducted semi-structured telephone interviews, using topic guides, with pregnant or recently
pregnant women, who were current or recent ex-smokers. To ensure broad views of ECs were obtained,
recruitment was from several geographical locations and via various avenues of recruitment. This included stop
smoking services, antenatal and health visitor clinics, a pregnancy website and an informal network. Participants
were 15 pregnant and 15 postpartum women, including nine current EC users, 11 ex-users, and 10 never-users. Five
women who were interviewed in pregnancy were later interviewed in postpartum to explore if their views had
changed. Audio data was transcribed verbatim and framework analysis was applied.
Results: Five main themes emerged: motivations for use (e.g., for stopping or reducing smoking), social stigma (e.g.
, avoiding use in public, preferring ‘discrete’ NRT), using the EC (e.g., mostly used at home); consumer aspects (e.g.,
limited advice available), and harm perceptions (e.g., viewed as less harmful than smoking; concerns about safety
and addiction).
Conclusions: ECs were viewed positively by some pregnant and postpartum women and seen as less harmful than
smoking and useful as aids for reducing and stopping smoking. However, due to perceived social stigma, some
women feel uncomfortable using ECs in public, especially during pregnancy, and had concerns about safety and
nicotine dependence. Health professionals and designers of EC interventions need to provide women with up-to-
date and consistent information and advice about safety and dependence, as well as considering the influence of
social stigma.
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Background
Maternal smoking in pregnancy is the main preventable
cause of morbidity and death among women and infants
[1, 2]. In high income countries smoking rates in preg-
nancy tend to be between 10 and 13% [3–5]. Despite
nicotine replacement therapy’s (NRT) effectiveness for
non-pregnant smokers [6], in pregnancy it has been
shown to be no more effective than placebo [7]. This is
most likely due to low adherence, as well as insufficient
dosage because of higher nicotine metabolism in preg-
nancy [7]. Financial incentives have shown promise for
smoking cessation in pregnancy, but there are ethical
challenges [8]; for example, there is the possibility that
women might falsify their smoking status in order to re-
ceive the incentive. Electronic cigarettes (ECs) may have
a role to play, as they potentially address both nicotine
addiction and the behavioural aspects of smoking.
ECs are increasingly used in many countries, including
the US [9], and are the most popular cessation aid in the
UK [10]. It has been argued that the potential benefits of
ECs probably outweigh harms, and that ECs may have
an important role in harm reduction [11–13]. As regards
the prevalence of EC use in pregnancy, one recent US
study observed that 53% of 103 pregnant smokers re-
ported having tried ECs [14] and a nationally representa-
tive US survey found that 29% of 100 pregnant smokers
were currently using ECs [15]. The efficacy and safety of
using ECs in pregnancy is untested. Nicotine has the po-
tential to show teratogenic effects in the fetus [16], but
there is no evidence for this. ECs share a similar phar-
macokinetic profile to NRT, which does not appear to
have detrimental effects on offspring at birth or 2 years
postpartum, compared with placebo [17, 18]. In the UK,
it is recommended that pregnant women should not be
discouraged from using ECs for stopping smoking if they
have struggled to quit without a cessation aid [19]. How-
ever, due to lack of evidence on efficacy and safety, in
Australia [20] and the US [21] women are advised not to
use ECs in pregnancy.
While several studies have investigated views on EC
use in pregnancy, these have significant limitations
such as the inclusion of women who were neither
pregnant nor postpartum [22, 23], investigation of a
restricted set of views [22, 24], recruiting from one
geographical area [25, 26], and not distinguishing be-
tween smokers and ex/non-smokers [24, 27, 28].
Moreover, only one of these studies [25] included
postpartum women. In addition, besides one online
study [28], they were all conducted in the US. Given
these limitations, there are significant knowledge gaps
in this area. We attempted to overcome the limita-
tions of previous studies by conducting a UK-based
qualitative, in-depth exploration of pregnant and post-
partum women’s views and experiences of ECs.
Methods
A qualitative descriptive methodology was chosen,
allowing an in-depth approach to eliciting a rich descrip-
tion of views and experiences for individual women.
This approach also enabled the exploration of differ-
ences between individuals. A purposive sampling strat-
egy was adopted to ensure the inclusion of a wide
variation of participants to maximise the chances that a
full spectrum of views on e-cigarette use in pregnancy
were captured. Semi-structured telephone interviews
were conducted with 30 UK pregnant or recently preg-
nant (given birth in last 6 months) women,
self-reporting as current smokers (smoked in past
30 days) or recent ex-smokers (stopped smoking in 3
months before pregnancy or after finding out about
pregnancy). Women were recruited with various experi-
ence of ECs and at different gestations. Following their
initial interview, pregnant participants were invited to be
re-interviewed within 3 months of the birth, in order to
observe if views had changed.
The interview schedule and study materials were
reviewed by a Patient and Public Involvement (PPI) rep-
resentative (ex-smoker and current EC user). We also
consulted a Smokers Panel of the UK Centre for To-
bacco and Alcohol Studies for advice on the recruitment
and research process. Interviews were conducted be-
tween October 2015 and October 2016. We used the
Consolidated Criteria for Reporting Qualitative Research
tool to promote a comprehensive report of the methods
and findings [29].
Recruitment and screening procedures
Participants were purposively sampled from the follow-
ing groups: current EC users (used EC in previous
30 days), ex-users (used EC, but not in last 30 days);
from each trimester of pregnancy, and from varying
stages within 6 months postpartum. Various sites were
used to place recruitment adverts: UK Stop Smoking
Services (SSS), hospital antenatal clinics and health vis-
itor clinics in locations across England and Scotland; so-
cial media (Facebook pages of the Nottingham Smoking
in Pregnancy Research group (www.facebook.com/
mumssmokingresearch/) and Tommy’s pregnancy char-
ity (https://www.facebook.com/tommys/) and the PPI
representative’s Twitter account); an advert on the preg-
nancy website Mumsnet (www.mumsnet.com); and
through informal networks. Women attending SSS or
clinics were informed of the study by a researcher or
stop smoking advisor and contact details of those inter-
ested were sent to a researcher.
Participant consent
Women selected for interview were sent a participant
information sheet. Approximately 1 week later, a
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researcher telephoned to seek verbal informed consent
to participate; pregnant women were asked for consent
to contact them again postpartum. Women were ineli-
gible if they could not understand the study procedure
sufficiently or were under 16 years. Background ques-
tions included: age, ethnicity, gestation, smoking status,
whether living with a partner, age left full-time education
and employment. Ex and current EC users were asked
about the frequency of EC use: (i) EC used daily (inten-
sive users); (ii) ECs used regularly but not daily (inter-
mittent users); (iii) ECs only used once or twice, or
occasionally (triers).
Interviews
Two experienced, female researchers conducted the in-
terviews (KB: PhD, midwife, non-smoker and SO: PhD,
health psychologist, non-smoker). The interviewers in-
troduced themselves as researchers working at the Uni-
versity of Nottingham. Interviews were audio recorded.
Data were transcribed verbatim by a transcriber external
to the research team. Interviewees received a £15 shop-
ping voucher. This payment was not offered on recruit-
ment adverts.
Interview questions were adapted from previous topic
guides related to ECs for smokers [30–33], with
pregnancy-specific questions added. The main topics
were: patterns of EC use (including motivations for using
ECs), perceived social norms, views on ECs compared
with cigarettes and NRT, views on support with using
ECs and on legislation and advertising (see Additional
files 1, 2, 3, 4, 5 and 6). Interview questions differed
slightly according to participant’s experience of ECs.
After interviewing 30 participants, and conducting initial
coding, we reflected on whether data saturation had
been reached. For those pregnant women who were
interviewed a second time, during postpartum, we cov-
ered the same topics as in pregnancy and focussed on
changes in views and experiences since the first inter-
view. For the latter interviews, we interviewed all the
women who were willing and we did not attempt to
reach data saturation.
Analysis
The framework method of thematic analysis was used to
manage, summarize and analyse the data [34]. Researchers
produced a set of framework matrices according to inter-
viewees level of experience of ECs and whether they were
pregnant or postpartum; thus, in total, there were six
matrices (i.e., pregnant/current EC user, pregnant/ex-user,
pregnant/never user, postpartum/current user, postpar-
tum/ex-user, postpartum/never user). This enabled re-
searchers to gain insight into the views and experiences of
each participant, while also identifying any differences be-
tween participants according to their experience of ECs.
Interviews from women who were interviewed twice
(pregnancy and postpartum) were compared to explore if
views had changed. The analysis was both inductive, from
the accounts (experiences and views) of participants, and
deductive, through being informed by existing literature
as reflected in the study objectives and the topics chosen
for the interviews.
First, KB and SO independently read and open coded all
the transcripts line by line, referring to any notes made
during the interviews. Also, in order to gain familiarity
with the dataset, these two researchers listened to all the
recordings. These researchers then met to discuss their re-
spective codes and agree the codes and define code cat-
egories representing conceptually related codes that
together formed a ‘working’ analytical framework. The
transcripts were then independently coded a third time by
either MU, FN, SC, LB or RW (all non-smokers), using
the working framework and noting any codes that devi-
ated from the framework. All the researchers then dis-
cussed possible refinements to the codes and categories.
The revised analytical framework was then applied to each
transcript to attach the final codes and to identify particu-
larly meaningful extracts of text to be transferred to an
Excel spreadsheet, consisting of one row per participant
and a column per code. The matrix was then reviewed by
KB and SO, with discussion with the entire team, to iden-
tify, label and refine the themes which best explained the
data. To increase the integrity of the findings, attention
was given to deviant cases. NVivo 11 software was used to
assist with coding and analysis.
Results
One hundred twenty-three women were eligible and
interested in participating in the study; 30 (26%) were
contactable and consented to an interview. Participants
were recruited from: SSS (Glasgow (n = 4), Leicester
(n = 7), London (n = 2)), Nottinghamshire antenatal
clinic (n = 4) and health visitor clinics (n = 10),
Tommy’s Facebook (n = 2), and informally (n = 1).
There were nine current-EC users, 11 ex-users and 10
never-users; 16 smoked and 14 were ex-smokers (see
Table 1). Seven of the nine current EC users were dual
users of cigarettes and ECs. Participants were aged 21 to
38 years, the majority were white British, lived with a
partner, did not attend formal education beyond 18 years
and were employed. Among the 15 pregnant women,
three were in the first trimester (≤ 12 weeks gestation),
seven in the second trimester (13 to 26 weeks), and five
in the third (27–40 weeks). Fifteen women were postpar-
tum: six were 0–3 months postpartum and nine were 4–
6 months. Ten pregnant women gave consent to be
re-interviewed postpartum and, of those, five were inter-
viewed and five were uncontactable. Two of the partici-
pants changed their smoking/EC status by the second
Bowker et al. BMC Pregnancy and Childbirth  (2018) 18:233 Page 3 of 10
Table 1 Characteristics of participants
ID Smoking
status
EC
status
EC level of
use
Age
range
Weeks’ gestation/
months postpartum
Living
with
partner
Age left
Education
Ethnicity Employed Interviewed second time
Smoking status and EC
1 ex-
smoker
ex-user trier 30–
39
37 weeks yes 17 white British yes No change: smoker/ex EC
user
2 ex-
smoker
ex-user trier 30–
39
37 weeks yes 16 white British yes
3 ex-
smoker
never
user
n/a 30–
39
5 months
postpartum
yes 21 Asian yes
4 ex-
smoker
ex-user trier 20–
29
36 weeks yes 18 white British yes
5 smoker current
user
intermittent 20–
29
6 months
postpartum
yes 18 white British yes
6 smoker current
user
intermittent 30–
39
10 weeks yes 26 white British yes
7 smoker current
user
intensive 20–
29
4 months
postpartum
yes 16 white British yes
8 smoker current
user
intensive 20–
29
25 weeks yes 19 white British yes
9 smoker ex-user intensive 20–
29
27 weeks no 16 white British no No change: smoker/ ex EC
user
10 ex-
smoker
current
user
intensive 20–
29
11 weeks no still in
education
white British yes
11 smoker never
user
n/a 30–
39
33 weeks yes 18 white British yes
12 smoker ex-user intermittent 30–
39
19 weeks no 16 white British no
13 ex-
smoker
never
user
n/a 30–
39
19 weeks yes 16 white British no
14 ex-
smoker
ex-user trier 20–
29
16 weeks yes 17 white British no No change: ex-smoker/ ex
EC user
15 smoker never
user
n/a 30–
39
19 weeks no 16 white British yes
16 ex-
smoker
ex-user trier 20–
29
35 weeks no 18 white British yes
17 smoker never
user
n/a 20–
29
12 weeks no 15 White/ black
Caribbean
yes Change: smoker/ ex EC
user (trier)
18 smoker ex-user intensive 20–
29
4 months
postpartum
yes 16 white British yes
19 ex-
smoker
current
user
intermittent 20–
29
21 weeks yes 16 white British yes Change: Smoker/ current
EC user
20 smoker never
user
n/a 20–
29
4 months
postpartum
no 15 white British no
21 ex-
smoker
never
user
n/a 20–
29
4 months
postpartum
yes 17 white British yes
22 smoker current
user
intermittent 20–
29
1 month postpartum no 23 black
Caribbean
yes
23 ex-
smoker
ex-user trier 20–
29
< 1 month
postpartum
yes 16 white British yes
24 smoker current
user
intensive 30–
39
5 months
postpartum
yes 22 white Asian yes
25 smoker never
user
n/a 20–
29
3 months
postpartum
yes 16 white British yes
26 smoker intensive yes 15 white British yes
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interview; one smoker/never EC user tried an EC since
the interview and an ex-smoker/current EC user had
returned to smoking. Interviews lasted for a mean (SD)
29 (8.7) minutes (range 18 to 53 min). We considered
that data saturation and been reached following the ini-
tial 30 interviews.
The initial codes were very similar for each level of ex-
perience of using ECs as well as for pregnancy and post-
partum women, except that aspects related to triggers for
use and experiences of use were not relevant for never
users. Therefore, it was decided that a common analytical
framework would be developed, while noting any diver-
gence for particular sub-groups of participants. The
framework included six categories: social factors, general
experience and usage, patterns of usage, comparison of
ECs and NRT, perceived benefits of ECs and negative
views on ECs; nested under these categories were a total
of 32 codes (see Additional file 7). Review of the matrices,
through discussion between the entire team, suggested
that five main themes offered the best explanation of the
data: motivations to use ECs, social stigma, using the EC,
consumer aspects, and harm perceptions. The process of
defining and labelling the themes was influenced by both
the study objectives and by new concepts identified in-
ductively from the data. Any differences in views accord-
ing to level of experience of ECs or between pregnant and
postpartum women are highlighted below. When preg-
nant women were interviewed for a second time at post-
partum their views appeared unchanged except regarding
the perceived stigma of ECs (see ‘Social Stigma’ theme).
Motivations for use
Most women were motivated to quit smoking; some felt
that ECs could help them quit and dual users of ECs
and cigarettes said they felt that ECs helped them to re-
duce their smoking.
‘I tried them but at the time [prior to pregnancy] I
didn’t really have the motivation to stop properly but
then, as I say, when I fell pregnant this time the first
thing I did was buy an electronic cigarette’.
(06 antenatal smoker and current EC user)
The majority indicated that they believed ECs were a
less harmful alternative to smoking during pregnancy, re-
ducing foetal exposure to toxins. Most women were aware
that ECs usually contained nicotine but were unaware of
other ingredients. Some said that ECs would reduce
smoke odours on their clothes, in their home and on their
children. A few felt ECs were safer than cigarettes for
second-hand smoke exposure.
‘it [EC] doesn’t pass on second-hand smoke, because
even if the baby was close-by, which I wouldn’t have a
baby close-by, it wouldn’t be dangerous’.
(19 antenatal ex-smoker and current EC user)
Most interviewees felt ECs were a cheaper alter-
native to smoking. A few women were motivated to
use an EC based on cost alone. In terms of what
first triggered women to use ECs, some women
were introduced to ECs, and encouraged to quit
using ECs, by family and friends. A few tried ECs
after recommendations from a health professional.
Others reported experimenting out of curiosity,
often on the ‘Spur of the moment’ (09 antenatal
ex-smoker and ex-EC user) and these women gen-
erally reported they were not ready to quit, so
didn’t pursue the EC.
‘They [family] were a lot happier about me using that
[EC] than obviously smoking. My Mum actually
bought me the e-cigarette and she never ever bought
me cigarettes in my life’.
(08 antenatal smoker and current EC user)
Table 1 Characteristics of participants (Continued)
ID Smoking
status
EC
status
EC level of
use
Age
range
Weeks’ gestation/
months postpartum
Living
with
partner
Age left
Education
Ethnicity Employed Interviewed second time
Smoking status and EC
current
user
20–
29
3 months
postpartum
27 ex-
smoker
ex-user trier 20–
29
4 months
postpartum
yes 21 white British yes
28 ex-
smoker
never
user
n/a 20–
29
3 months
postpartum
no 21 White/ black
Caribbean
yes
29 ex-
smoker
never
user
n/a 20–
29
< 1 month
postpartum
yes 21 white British yes
30 smoker ex-user trier 20–
29
4 months
postpartum
yes 21 white British yes
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A few women, having quit smoking, said they were
more likely to use NRT than ECs if they relapsed, primar-
ily due to the potential for ECs to steer them back to
smoking, as a result of the similarity to smoking. Some
‘never’ and ex-users believed NRT would better support a
quit attempt than ECs as regards ‘weaning off ’ nicotine.
Social stigma
Most women expressed feeling uncomfortable (both ac-
tual and perceived experience) about using ECs in public
during pregnancy and, for some, also in postpartum, es-
pecially when with children. The women said they felt
that they would be judged and perceived as a bad
mother. Two women who were interviewed again after
pregnancy indicated they felt more comfortable about
the idea of using ECs after the pregnancy, believing that
there was less public judgement and less risk to the baby
at this time. Some women also expressed a strong belief
that it was socially unacceptable for a pregnant woman
to smoke or vape in public.
‘If I was pregnant I would feel embarrassed because I
think it looks disgusting. If I’m honest, pregnant
women drinking or smoking any type of fags, cigar,
electronic fags, I don’t think it looks very nice, so I
wouldn’t do it pregnant in public. Afterwards I
wouldn’t be bothered. I suppose it depends if I had the
baby with me in a pushchair I wouldn’t be too keen on
the idea.’
(04 antenatal ex-smoker and ex-EC user)
Compared with cigarette smoking, some felt it was
more socially acceptable to use an EC and felt empath-
etic towards pregnant women using ECs as they could
relate to the struggles of cessation. A few mentioned that
a benefit of NRT is that it can be administered discreetly
in public.
Using the EC (EC current users/ex-users only)
Regarding the context of where the EC was used, EC
‘triers’ reported vaping with friends and family, often in
the home environment. Regular users generally reported
vaping in similar environments as for smoking, often the
home, workplace or car. A few said that, similarly to
smoking, they avoided using ECs around their children.
Some said they were attracted by ECs as they replicated
and substituted smoking, especially in terms of inhaling
and blowing vapour and the hand-to-mouth action. One
woman, who had struggled to quit using NRT, said she
found that ECs helped her as they assisted with both the
addiction and behavioural aspects of smoking. However,
some ex-users indicated they felt ECs were too much of a
reminder of smoking but, compared with a cigarette,
didn’t provide the same satisfaction and often required
use over longer periods in order to alleviate cravings.
‘One thing I missed when I have quit smoking is
inhaling the smoke, so when I used an e-cigarette
obviously you’ve got that kind of experience of inhaling
the vapour. It was too much, it was too similar to
having a cigarette, so it made me miss it even more.’
(01 antenatal ex-smoker and ex-EC user)
Some women reported negative first experiences of
ECs; others felt side effects reduced as they adapted.
One woman compared her initial experience to learning
to smoke.
Consumer aspects
Among EC users/ex-users there was a general preference
for smaller and lighter ECs; one woman reported she
liked the convenience of it fitting in her handbag. Most
participants were aware of the variety of flavours and
some were aware of various nicotine strengths. To
economise, a few women purchased the cheapest EC;
however, they also felt the price of ECs reflected their
value, with more expensive devices being more
user-friendly. Women tended to either choose an EC im-
pulsively, based on cost, or based on the advice of
friends/family. Many had not received instructions about
their device from the retailer or on the EC packaging,
leaving some feeling uninformed.
‘When you are pregnant you want to know….how is
the best way to use it [EC] to help you stop….you
literally had to go and buy it like a loaf of bread’.
(07 postpartum smoker and current EC user)
Rather than receiving information about ECs from re-
tailers, women generally said they would prefer to re-
ceive information from a health professional or through
National Health Service leaflets or websites.
Harm perceptions
Never-users, in particular, and some ex-users, said they
felt there was a lack of information available about the
safety of ECs, which led to fears. In order to make an in-
formed decision about whether to use ECs, they said
they needed further information and advice, preferably
from health professionals.
‘Everyone just says ‘oh there’s only five chemicals in an
e-cigarette, while there’s 4000 in a cigarette’ but my
concern was those five chemicals that are in the e-
cigarette’.
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(18 postpartum smoker and ex-EC user)
Women were asked whether they thought ECs should
be made available on prescription and many felt it was im-
portant to first establish their safety. One smoker and
never user said that she would require the government to
provide assurance on their safety in pregnancy before she
would consider using one.
‘Yeah and I think obviously if there was some sort of
government stamp on it or you know you don’t buy
toys without having something, you don’t buy anything
without, even the bad stuff you know, you buy a packet
of cigarettes and the government have put what it can
do to you on it, with all the pictures. Whereas there’s
nothing is there? There’s no nothing, no good, no bad,
no nothing.’
(15 antenatal smoker and never user)
Some women indicated they felt more confident about
NRT because the health service clearly advocated it, whereas
they had received conflicting advice from health profes-
sionals about using ECs. Concerns about the safety of ECs
were heightened by negative media reports, referring to mal-
functioning devices, links to cancer or other health harms. A
couple of women were concerned that ECs were becoming
a fashion accessory, and one woman reported ECs had
appealed to her young nephew.
Several women were worried that vaping might in-
crease their consumption of nicotine compared with
smoking:
‘Obviously with a cigarette you can only smoke it for
so long till it’s finished, but with an e-cigarette you can
smoke for as long as you want to. So sometimes, I
guess, I was taking in more than the usual nicotine in-
take that I would have done with a cigarette.’
(01 antenatal ex-smoker and ex-EC user)
‘So my friends that have used them they’re constantly
in their mouth whereas a cigarette, you have a
cigarette and then you don’t have another one for, say,
three hours.’
(13 antenatal ex-smoker never user)
Discussion
This study explored in-depth views surrounding EC use
in both pregnancy and postpartum, identified five main
themes, and gained important new insights that are spe-
cific to this population. Some pregnant and postpartum
women viewed ECs as less harmful than smoking and as
aids for reducing and stopping smoking. However, due
to perceived social stigma, some felt uncomfortable
using ECs in public, especially during pregnancy. They
also had concerns about safety and nicotine dependence,
requesting more consistent information from health pro-
fessionals. Some expressed a preference for NRT over
ECs; they felt that NRT was both consistently sanctioned
by health professionals and could be used more dis-
cretely than ECs.
Strengths of this study include the use of a
broad-based topic guide and a series of individual inter-
views to capture the views of UK women with varying
experience of ECs. Additionally, we recruited women
from a number of UK regions and recruitment sites. To-
gether, this approach increases the likelihood of captur-
ing a diverse set of views. The use of framework analysis
ensured data analysis was transparent and enabled all
members of the research team to contribute.
There were also limitations. Telephone rather than
face-to-face interviews were used; we were therefore un-
able to gather potentially important contextual informa-
tion about the participant’s environment. However,
considering both the wide geographical spread of the
participants and that pregnancy is a busy time with
many antenatal appointments, telephone interviews were
considered the most practicable option. As regards re-
flexivity, there is the potential for unconscious, or even
conscious, bias as this research was conducted in a UK
research and policy climate in which ECs have largely
been advocated as a less harmful alternative to smoking
[11]. As with most qualitative research [35], the
intention of the study was not to ensure the findings are
fully representative of the wider population; although,
the ethnic and education characteristics of women (i.e.,
mostly white ethnicity and not receiving formal educa-
tion beyond 18 years) suggest that they are fairly typical
of women who smoke in pregnancy [3]. Our intention
was, purposively, to capture potential diversity around
the phenomenon of views on and experiences of ECs
during pregnancy and postpartum. Thus, as we purpos-
ively sampled for both level of experience with ECs and
pregnancy versus postpartum, there was great hetero-
geneity in the characteristics of the sample. This can
make it difficult to draw overall conclusions. Despite
this, except for instances where experiences were irrele-
vant to the ‘never-users’ sub-group (e.g., regarding trig-
gers for using ECs), the findings were very similar for
the different sub-groups.
As with smokers in general [33], there were mixed find-
ings concerning women’s experiences of using ECs; some
favoured ECs because they mimicked smoking, while, con-
versely, others didn’t like ECs as they reminded them of
smoking. Again, as found in the general population [36],
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most women were interested in using ECs either to stop
smoking or to reduce their smoking with dual use of ECs
and cigarettes. The majority (seven of nine) of the current
EC users were dual users of ECs and cigarettes and these
women said they felt that ECs helped them to reduce their
smoking. Outside of pregnancy, 45% of British EC users
report dual use [36]. The results of a recent nationally rep-
resentative US survey suggest that rates of dual use may
be higher in pregnancy than outside for pregnancy: 79% of
34 pregnant women using ECS were currently still smok-
ing and the remaining 21% were ex-smokers [15]. Dual
use of NRT and cigarettes is also common during preg-
nancy [37]. Dual use may increase attempts to stop smok-
ing [12, 38], although it is unclear whether this increases
cessation [39]. Among smokers in general, dual use is
likely to maintain similar levels of carcinogens and toxi-
cants as smoking [14], although it is not known if this is
also the case in pregnancy.
Interestingly, many of the women said that they began
using ECs spontaneously, ‘on the spur of the moment’.
This may need to be considered in public health policy
as ECs are increasingly widely used and available, and
pregnant women may be frequently exposed to them
and readily triggered to experiment with them.
This is the first study to report that, due to perceived
social stigma, some women would avoid using ECs in
public while pregnant or with an infant. Similar to US
findings [26], others felt that using an EC was less stig-
matising than smoking and would feel empathetic to-
wards pregnant women using ECs, as they understood
the difficulties of cessation. The presence of perceived
social stigma contrasts with non-pregnant populations,
where ECs are largely viewed as sociable and enjoyable
[31, 39, 40], but is consistent with the strong social
stigma felt by pregnant smokers [41–43] and with nega-
tive public perceptions of smoking in pregnancy [44].
Moreover, a US survey observed that most people view
ECs as being as harmful, if not more harmful, as smok-
ing during pregnancy [45]. Pregnant women hide their
smoking [43] and, similarly, we observed that women
often preferred vaping at home and in other places
where they usually smoked. Moreover, there was no in-
dication that women vaped with others or shared their
ECs. These women may be responding to the societal
focus on maternal responsibility and the notion of the
‘bad mother’, in relation to health threats to the fetus,
which can serve to marginalise and stigmatise women
[46]. Related to this, due to its discrete nature, some
women favoured NRT over ECs; clinicians may need to
be sensitive to this preference and EC manufacturers
might want to consider producing more discrete devices
that are not perceived to give a ‘bad’ impression. A fur-
ther, related, new finding is that a few women felt it was
more socially acceptable to use an EC after having a
baby, compared with pregnancy, as they felt there was
less stigma and less harm for the baby. Thus, ECs may
be suitable for preventing return to smoking in the post-
partum period, although it has also been observed that
women who use ECs in pregnancy may be at risk of re-
suming smoking after the birth [26].
Consistent with US research among pregnant women
[22, 25, 26, 47], many considered ECs to be safer than
cigarettes during pregnancy and around infants. They
also had concerns about harm and felt that health pro-
fessionals needed to provide more consistent safety in-
formation. There were also worries that ECs continue or
even increase nicotine addiction. Among non-pregnant
smokers, laboratory analysis suggests it is unlikely vapers
would consume more nicotine than when smoking, as
they self-titrate to satisfy their cravings [48, 49]. The
women’s need for more safety information may be partly
alleviated by recent UK guidance to help healthcare pro-
fessionals to advise pregnant women about ECs [19].
This guidance states the likely relative harms of ECs ver-
sus smoking and advises that NRT is the recommended
option in pregnancy but that women should not be dis-
couraged from using ECs if they help them to stay
smoke free. Together, these findings highlight the urgent
need for studies investigating EC toxicants and carcino-
gens for mother and fetus, similar to studies conducted
with non-pregnant smokers [13].
Conclusions
ECs were viewed positively by some pregnant and post-
partum women and seen as less harmful than smoking
and useful as aids for reducing and stopping smoking.
However, due to perceived social stigma, some women
feel uncomfortable using ECs in public, especially during
pregnancy, and had concerns about safety and nicotine
dependence. These findings highlight the need for both
health professionals and designers of EC interventions to
provide women with up-to-date and consistent informa-
tion and advice, as well as considering the influence of
social stigma. There remains a need for investigations of
any harms of ECs for the mother and fetus and of the ef-
fectiveness of these devices for helping women to reduce
and stop smoking during pregnancy and postpartum.
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